{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T09:47:59Z","timestamp":1783763279907,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":47,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.vaccine.2022.12.016","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T15:21:22Z","timestamp":1671031282000},"page":"778-786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of patient and provider nudges on addressing herpes zoster vaccine series completion"],"prefix":"10.1016","volume":"41","author":[{"given":"Justin","family":"Gatwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brookhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujith","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Gravlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Hohmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.12.016_b0005","unstructured":"Shingles (Herpes Zoster). CDC. Published April 12, 2021. Accessed June 29, 2021. https:\/\/www.cdc.gov\/shingles\/index.html."},{"issue":"8","key":"10.1016\/j.vaccine.2022.12.016_b0010","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1080\/21645515.2021.1879579","article-title":"Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019","volume":"17","author":"Patterson","year":"2021","journal-title":"Hum Vaccines Immunother"},{"issue":"6","key":"10.1016\/j.vaccine.2022.12.016_b0015","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.vaccine.2020.12.076","article-title":"Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older","volume":"39","author":"Ackerson","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.12.016_b0020","unstructured":"Shingrix Shingles Vaccination: What Everyone Should Know. CDC. Published March 25, 2021. Accessed June 28, 2021. https:\/\/www.cdc.gov\/vaccines\/vpd\/shingles\/public\/shingrix\/index.html."},{"key":"10.1016\/j.vaccine.2022.12.016_b0025","unstructured":"Complications of Shingles (Herpes Zoster). CDC. Published April 12, 2021. Accessed June 28, 2021. https:\/\/www.cdc.gov\/shingles\/about\/complications.html"},{"key":"10.1016\/j.vaccine.2022.12.016_b0030","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12879-018-3395-z","article-title":"Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above","volume":"18","author":"Curran","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2022.12.016_b0035","unstructured":"Cubanski J, Neuman T . Who Didn\u2019t Get a Second Shingrix Shot? Implications for Multidose COVID-19 Vaccines. KFF. Published December 14, 2020. Accessed June 28, 2021. https:\/\/www.kff.org\/medicare\/issue-brief\/who-didnt-get-a-second-shingrix-shot-implications-for-multidose-covid-19-vaccines\/."},{"key":"10.1016\/j.vaccine.2022.12.016_b0040","unstructured":"Demographics of Mobile Device Ownership and Adoption in the United States. Pew Research Center: Internet, Science & Tech. Accessed June 28, 2021. https:\/\/www.pewresearch.org\/internet\/fact-sheet\/mobile\/."},{"key":"10.1016\/j.vaccine.2022.12.016_b0045","doi-asserted-by":"crossref","unstructured":"Vodopivec\u2010Jamsek V, Jongh T de, Gurol\u2010Urganci I, et al. Mobile phone messaging for preventive health care. Cochrane Database Syst Rev. 2012;(12). doi:10.1002\/14651858.CD007457.pub2.","DOI":"10.1002\/14651858.CD007457.pub2"},{"key":"10.1016\/j.vaccine.2022.12.016_b0050","doi-asserted-by":"crossref","unstructured":"Jongh T de, Gurol\u2010Urganci I, Vodopivec\u2010Jamsek V, et al. Mobile phone messaging for facilitating self\u2010management of long\u2010term illnesses. Cochrane Database Syst Rev. 2012;(12). doi: https:\/\/doi.org\/10.1002\/14651858.CD007459.pub2.","DOI":"10.1002\/14651858.CD007457.pub2"},{"key":"10.1016\/j.vaccine.2022.12.016_b0055","doi-asserted-by":"crossref","unstructured":"Whittaker R, McRobbie H, Bullen C, et al. Mobile phone\u2010based interventions for smoking cessation. Cochrane Database Syst Rev. 2016;(4). doi: https:\/\/doi.org\/10.1002\/14651858.CD006611.pub4.","DOI":"10.1002\/14651858.CD006611.pub4"},{"issue":"3","key":"10.1016\/j.vaccine.2022.12.016_b0060","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0884","article-title":"Mobile Phone Interventions for Adolescent Sexual and Reproductive Health: A Systematic Review","volume":"138","author":"L\u2019Engle","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.12.016_b0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.invent.2018.06.002","article-title":"Using text message reminders in health care services: A narrative literature review","volume":"13","author":"Schwebel","year":"2018","journal-title":"Internet Interv"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.016_b0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jadohealth.2016.09.011","article-title":"Effects of phone and text message reminders on completion of the human papillomavirus vaccine series","volume":"60","author":"Rand","year":"2017","journal-title":"J Adolesc Health"},{"issue":"5","key":"10.1016\/j.vaccine.2022.12.016_b0075","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jadohealth.2014.10.273","article-title":"Effectiveness of centralized text message reminders on human papillomavirus immunization coverage for publicly insured adolescents","volume":"56","author":"Rand","year":"2015","journal-title":"J Adolesc Health"},{"issue":"4","key":"10.1016\/j.vaccine.2022.12.016_b0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amepre.2015.04.029","article-title":"Encouraging Influenza Vaccination Among Text4baby Pregnant Women and Mothers","volume":"49","author":"Jordan","year":"2015","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.016_b0085","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2196\/jmir.5235","article-title":"Text messaging for exercise promotion in older adults from an upper-middle-income country: Randomized controlled trial","volume":"18","author":"Muller","year":"2016","journal-title":"J Med Internet Res"},{"issue":"12","key":"10.1016\/j.vaccine.2022.12.016_b0090","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1080\/21645515.2016.1215393","article-title":"Community pharmacies as sites of adult vaccination: A systematic review","volume":"12","author":"Burson","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2022.12.016_b0095","unstructured":"Centers for Disease Control and Prevention. Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults, United States. Accessed 6 June 2022. Available at: https:\/\/www.cdc.gov\/flu\/fluvaxview\/dashboard\/vaccination-administered.html"},{"issue":"37","key":"10.1016\/j.vaccine.2022.12.016_b0100","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1016\/j.vaccine.2018.07.027","article-title":"National survey of pharmacy-based immunization services","volume":"36","author":"Westrick","year":"2018","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2022.12.016_b0105","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2016.08.085","article-title":"Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis","volume":"34","author":"Isenor","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.12.016_b0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ssmph.2016.12.009","article-title":"Health lifestyle behaviors among US adults","volume":"1","author":"Saint Onge","year":"2017","journal-title":"SSM-Population Health"},{"issue":"4","key":"10.1016\/j.vaccine.2022.12.016_b0115","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.amepre.2022.04.018","article-title":"Impact of a clinical \u201cnudge\u201d on herpes zoster vaccine dose completion in community pharmacies","volume":"63","author":"Gatwood","year":"2022","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2022.12.016_b0120","unstructured":"Shingrix (Zoster Vaccine Recombinant, Adjuvanted) [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2021."},{"issue":"6","key":"10.1016\/j.vaccine.2022.12.016_b0125","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.sapharm.2014.01.002","article-title":"Addressing medication nonadherence by mobile phone: Development and delivery of tailored messages","volume":"10","author":"Gatwood","year":"2014","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.016_b0130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.sapharm.2015.04.007","article-title":"The impact of tailored text messages on health beliefs and medication adherence in adults with diabetes: A randomized pilot study","volume":"12","author":"Gatwood","year":"2016","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.016_b0135","first-page":"204","article-title":"The Management of Diabetes in Everyday Life (MODEL) Program: Development of a Tailored Text Message Intervention to Improve Diabetes Self-Care Activities among Underserved African American Adults","volume":"10","author":"Gatwood","year":"2020","journal-title":"Trans Behav Med"},{"key":"10.1016\/j.vaccine.2022.12.016_b0140","unstructured":"Fein AJ. The 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers, Drug Channels Institute. Published March 2022. Accessed May 25, 2022. https:\/\/drugch.nl\/pharmacy."},{"issue":"5","key":"10.1016\/j.vaccine.2022.12.016_b0145","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.sapharm.2017.06.001","article-title":"Application of the consolidated framework for implementation research to community pharmacy: a framework for implementation research on pharmacy services","volume":"13","author":"Shoemaker","year":"2017","journal-title":"Res Social and Adm Pharm"},{"key":"10.1016\/j.vaccine.2022.12.016_b0150","doi-asserted-by":"crossref","unstructured":"Porter AM, Fulco PP. Impact of a pharmacist-driven recombinant zoster vaccine administration program. J Am Pharm Assoc (2003). 2021; 61(2): e136-e139.","DOI":"10.1016\/j.japh.2020.11.011"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:21:16Z","timestamp":1759404076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22015304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0264410X22015304"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of patient and provider nudges on addressing herpes zoster vaccine series completion","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}